Share
Journal Information
Consensus document
Executive summary: Clinical practice guidelines on the management of resistant tuberculosis of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)
Adrian Sanchez-Montalvaa,b,c,1,
, José Antonio Caminerod,e,1, Mª Remedio Gunaf,g,h, Teresa Rodrígo Sanzi, Ramón Rabuñalj,b, Joan Pau Milletk,l,m,n, José Antonio Gullón-Blancoo, Luis Anibarrop,q, Guillermo Perez-Mendozar,s, Juan Francisco Medinat,u, Verónica González-Galánv,w,2, Eva Tabernerox,y,2, on behalf of the Writing committee of the Spanish MDR TB consortium (in alphabetical order) ◊
Corresponding author
a International Health Unit Vall d’Hebron-Drassanes, Infectious Diseases Department, Vall d’Hebron University Hospital, PROSICS Barcelona, Autonomous University of Barcelona, Spain
b Mycobacterial Infections Study Group (GEIM) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Madrid, Spain
c For Biomedical Research Centre in Infectious Diseases Network (CIBERINFEC), Carlos III Health Institute, Madrid, Spain
d Prof. Head of the Pulmonology Service at the Dr. Negrín General University Hospital, Las Palmas de GC, Spain
e Director of Scientific Activities ALOSA TB ACADEMY, Spain
f Microbiology Service, General University Hospital Consortium of Valencia, Valencia, Spain
g Department of Microbiology and Parasitology, Faculty of Medicine, University of Valencia, Mycobacterial Infections Study Group (GEIM) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Madrid, Spain
h SEIMC Quality Control, Madrid, Spain
i Integrated Research Program in Tuberculosis and Non-Tuberculous Mycobacteria (PII-TB&MNT), Centre for Biomedical Research in Public Health Network (CIBERESP), Barcelona Tuberculosis Research Unit, Spain
j Infectious Diseases Unit, Internal Medicine Department, Lucus Augusti University Hospital, Lugo, Spain
k Epidemiology Service, Public Health Agency of Barcelona, Barcelona, Spain
l Serveis Clínics, Barcelona, Spain
m Integrated Research Program in Tuberculosis (PII-TB) of the Spanish Society of Pneumology and Pathology of the Respiratory System (SEPAR), Barcelona, Spain
n Centre for Biomedical Research in Epidemiology and Public Health Network (CIBERESP), Carlos III Health Institute, Madrid, Spain
o Pulmonology Section, San Agustín University Hospital, Avilés, Spain
p Tuberculosis Unit, Infectious Diseases, Internal Medicine Service, University Hospital Complex, Pontevedra, Spain
q Immunology Research Group, Galicia Sur Health Research Institute, Spain
r Pulmonology Department, Dr. Negrín University Hospital of Gran Canaria, Las Palmas de GC, Spain
s PII-TB&MNT & SEPAR Study Group, Spain
t Medical-Surgical Unit of Respiratory Diseases (UMQER) Virgen del Rocío University Hospital, Seville, Spain
u Integrated Research Program in Tuberculosis and Non-Tuberculous Mycobacteria (PII-TB&MNT), Spain
v Clinical Unit of Infectious Diseases, Microbiology, and Clinical Parasitology (UCEIMP), Virgen del Rocío University Hospital, Seville, Spain
w Institute of Biomedicine of Seville (IBiS), Clinical and Molecular Microbiology Group, Mycobacteria Line, GEIM-SEIMC Study Group, PII-TB& MNT, SEPARATE, Spain
x Pulmonology Service, Cruces University Hospital (OSI EEC), Barakaldo, Spain
y BioBizkaia Health Research Institute, Spain
Ver másAnnex. Members of the Spanish MDR TB consortium group
Publish in
Enfermedades Infecciosas y Microbiología Clínica
Free access articles
Enferm Infecc Microbiol Clin. 2024;42:581-7
Enferm Infecc Microbiol Clin. 2024;42:281
Enferm Infecc Microbiol Clin. 2024;42:516-26
La Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica agradece la colaboración de:
SOCIOS PROTECTORES
-
- Pfizer GEP, S.L.U.
- Shionogi, S.L.U.
- AbbVie Spain, S.L.U.
- Gilead Sciences, S.L.U.
- Vircell Spain, S.L.U.
- Roche Diagnostics, S.L.U.
- ASTRAZENECA FARMACÉUTICA SPAIN, S.A.
- Qiagen Iberia S.L.
- Laboratorios ViiV Healthcare, S.L.
SOCIOS PATROCINADORES
- Becton Dickinson S.A.U.
- Janssen-Cilag, S.A.
- Angelini Farmacéutica, S.A.
- Biomerieux España, S,A.U.
- Merck Sharp & Dohme de España, S.A.
- Hologic Iberia, S.L.U.
- Laboratorios Menarini S.A.
- Accelerate Diagnostics S.L.
- Abbott Laboratories, S.A.
- Cepheid Iberia S.L.U.
- Illumina Productos de España. S.L.U.
- DiaSorin Iberia, S.A.
- GlaxoSmithKline, S.A.
- Sysmex España S.L.
Enfermedades Infecciosas y Microbiología Clínica follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals